Michael S. Weiss - 13 Jun 2023 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
Director
Signature
/s/ James F. Oliviero, Attorney-in-Fact
Issuer symbol
CKPT
Transactions as of
13 Jun 2023
Net transactions value
$0
Form type
4
Filing time
15 Jun 2023, 20:01:24 UTC
Previous filing
14 Mar 2023
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK Award $0 +17,483 +138% $0.000000 30,123 13 Jun 2023 See Note 3 F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 17,483 shares of restricted Common Stock will vest on June 13, 2026, subject to Mr. Weiss's continued service on the board on such date.
F2 Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board.
F3 The shares are held by Hawkins BioVentures, LLC, Mr. Weiss is the sole member.